These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19375659)

  • 21. [Genetic counselling is relevant in familial as well as sporadic cases of amyotrophic lateral sclerosis].
    Lindquist SG; Dunø M; Svenstrup K; Nielsen JE
    Ugeskr Laeger; 2014 Oct; 176(43):. PubMed ID: 25353674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis?
    Vasta R; Canosa A; Manera U; Di Pede F; Cabras S; De Marchi F; Mazzini L; Moglia C; Calvo A; Chio A
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):1017-1019. PubMed ID: 33563811
    [No Abstract]   [Full Text] [Related]  

  • 23. Amyotrophic lateral sclerosis.
    Perry JJ; Shin DS; Tainer JA
    Adv Exp Med Biol; 2010; 685():9-20. PubMed ID: 20687491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Superoxide dismutase-1 (SOD-1) gene mutation-dependent mechanisms of neural degeneration in amyotrophic lateral sclerosis].
    Iłzecka J
    Neurol Neurochir Pol; 2001; 35(3):461-9. PubMed ID: 11732268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS.
    Armstrong GA; Drapeau P
    Hum Mol Genet; 2013 Nov; 22(21):4282-92. PubMed ID: 23771027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic disorder in proteins involved in amyotrophic lateral sclerosis.
    Santamaria N; Alhothali M; Alfonso MH; Breydo L; Uversky VN
    Cell Mol Life Sci; 2017 Apr; 74(7):1297-1318. PubMed ID: 27838743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.
    Lattante S; Rouleau GA; Kabashi E
    Hum Mutat; 2013 Jun; 34(6):812-26. PubMed ID: 23559573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel FUS mutation in patients with sporadic amyotrophic lateral sclerosis and corticobasal degeneration.
    Nagayama S; Minato-Hashiba N; Nakata M; Kaito M; Nakanishi M; Tanaka K; Arai M; Akiyama H; Matsui M
    J Clin Neurosci; 2012 Dec; 19(12):1738-9. PubMed ID: 22999566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular mechanisms of ALS mutations - a loss or a gain of function?
    Haass C
    Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S17. PubMed ID: 24242032
    [No Abstract]   [Full Text] [Related]  

  • 31. RNA-binding proteins and RNA metabolism: a new scenario in the pathogenesis of Amyotrophic lateral sclerosis.
    Colombrita C; Onesto E; Tiloca C; Ticozzi N; Silani V; Ratti A
    Arch Ital Biol; 2011 Mar; 149(1):83-99. PubMed ID: 21412718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Playng defense against Lou Gehrig's disease.
    Aebischer P; Kato AC
    Sci Am; 2007 Nov; 297(5):86-93. PubMed ID: 17990828
    [No Abstract]   [Full Text] [Related]  

  • 33. Pur-alpha functionally interacts with FUS carrying ALS-associated mutations.
    Di Salvio M; Piccinni V; Gerbino V; Mantoni F; Camerini S; Lenzi J; Rosa A; Chellini L; Loreni F; Carrì MT; Bozzoni I; Cozzolino M; Cestra G
    Cell Death Dis; 2015 Oct; 6(10):e1943. PubMed ID: 26492376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of amyotrophic lateral sclerosis.
    Liscic RM; Breljak D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
    Wang T; Jiang X; Chen G; Xu J
    Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.
    Rothstein JD
    Ann Neurol; 2009 Jan; 65 Suppl 1():S3-9. PubMed ID: 19191304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a FUS splicing mutation in a large family with amyotrophic lateral sclerosis.
    Belzil VV; St-Onge J; Daoud H; Desjarlais A; Bouchard JP; Dupré N; Camu W; Dion PA; Rouleau GA
    J Hum Genet; 2011 Mar; 56(3):247-9. PubMed ID: 21160488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear pore destruction and loss of nuclear TDP-43 in FUS mutation-related amyotrophic lateral sclerosis motor neurons.
    Aizawa H; Teramoto S; Hideyama T; Kato H; Terashi H; Suzuki Y; Kimura T; Kwak S
    J Neurol Sci; 2022 May; 436():120187. PubMed ID: 35232585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.